Here is how MacroGenics (MGNX) and C4 Therapeutics, Inc. (CCCC) have performed compared to their sec

Seeking Alpha welcomed 38 new analysts in September 2026. This article showcases their top picks and

ROCKVILLE, MD, Sept. 09, 2026 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceuti

Positive risk/reward with MacroGenics trading at a discount to its $327 million cash position or $5.

Bank of America Corp DE increased its stake in shares of MacroGenics, Inc. (NASDAQ: MGNX) by 30.7% d

Here is how MacroGenics (MGNX) and CareDx (CDNA) have performed compared to their sector so far this

The company's HIV franchise is stronger than ever, and it's adding a stable of oncology drugs.

B. Riley Securities analyst Mayank Mamtani maintains Macrogenics (NASDAQ:MGNX) with a Buy and rai

MacroGenics (MGNX) came out with a quarterly loss of $0.27 per share versus the Zacks Consensus Esti

Macrogenics (NASDAQ:MGNX) reported quarterly losses of $(0.27) per share which missed the analyst co

ROCKVILLE, Md., Aug. 13, 2026 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage

MacroGenics, Inc. (NASDAQ:MGNX), a clinical-stage biopharmaceutical company focused on developing in

ROCKVILLE, MD, Aug. 11, 2026 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage

Shares of MacroGenics, Inc. (NASDAQ: MGNX - Get Free Report) have been given an average rating of "H

MacroGenics is affirmed as a 'Buy' due to a de-risked operational runway and promising B7-H3 ADC pip

MacroGenics, Inc. (NASDAQ:MGNX), a clinical-stage biopharmaceutical company focused on developing in

Interim Phase 1 results accepted for poster presentation at ESMO Congress 2026 Achieved pre-specifie

Does MacroGenics (MGNX) have what it takes to be a top stock pick for momentum investors? Let's find

ROCKVILLE, MD, July 02, 2026 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage

MacroGenics, Inc. (NASDAQ:MGNX), a clinical-stage biopharmaceutical company focused on developing in

ROCKVILLE, MD, June 22, 2026 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage

ROCKVILLE, MD, May 14, 2026 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutica

MacroGenics (MGNX) came out with a quarterly loss of $0.58 per share versus the Zacks Consensus Esti

Macrogenics (NASDAQ:MGNX) reported quarterly losses of $(0.58) per share which beat the analyst cons

ROCKVILLE, Md., May 13, 2026 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage

Harmonic Inc (HLIT) rose in pre-market trading after beating earnings expectations & raising gui

•MacroGenics to receive $122. 5 million upfront payment from Bora upon closing•Transaction includes

MacroGenics, Inc. (NASDAQ:MGNX), a clinical-stage biopharmaceutical company focused on developing in

Barclays analyst Etzer Darout maintains Macrogenics (NASDAQ:MGNX) with a Overweight and raises th

Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earning

Gainers PaxMedica, Inc. (NASDAQ: PXMD) shares climbed 173.8% to $8.35. PaxMedica announced the pu

Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earn

The disinflationary trend continued in July, even though the annual CPI inflation rate saw a slight

Companies Reporting Before The Bell • Sony Group (NYSE:SONY) is estimated to report quarterly earni

Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earn

Companies Reporting Before The Bell • Sportradar Gr (NASDAQ:SRAD) is estimated to report quarterly

U.S. stocks traded slightly lower, with the Nasdaq Composite dropping around 0.2% on Monday. Here ar